featured
Acalabrutinib in Treatment-Naïve Chronic Lymphocytic Leukemia
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Blood
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Acalabrutinib in Treatment-Naïve Chronic Lymphocytic Leukemia
Blood 2021 Mar 30;[EPub Ahead of Print], JC Byrd, JA Woyach, RR Furman, P Martin, S O'Brien, JR Brown, DM Stephens, J Barrientos, S Devereux, P Hillmen, JM Pagel, A Hamdy, R Izumi, P Patel, MH Wang, N Jain, WG WierdaFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.